Testing a combination treatment for early memory loss and Alzheimer's disease

This research study is testing whether DAOIB—a medication that works on a specific brain chemical—combined with an antioxidant drug might help people with early Alzheimer's disease or mild cognitive impairment more than DAOIB alone. Previous research suggests that both types of medication may help improve memory and thinking. This study wants to find out if using them together is even more effective.

Scientists have seen that medications targeting brain chemistry and antioxidant medications each show promise in early dementia, but it's not yet clear whether combining them offers better benefits than using just one. This trial will help answer that question.